Cipher Pharma (CPHR) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Cipher Pharma (CPHR) Misses Q1 EPS by 6c

Cipher Pharmaceuticals Reports Q1 2016 Financial Results

May 5, 2016 7:01 AM EDT

-     Revenue increased 23%-     Delivered on multiple commercial and regulatory milestones-     Positive cash from operating activities of $1.4 million while investing in future growth

MISSISSAUGA, ON, May 5, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX: CPH) ("Cipher" or "the Company") today announced its financial and operational results for the three months ended March 31, 2016. Unless otherwise noted, all figures are in U.S. currency.

"In the first quarter, we delivered on several key commercial milestones that strengthen and diversify our product portfolio and position the company to... More